Teal Health

Special thank you to Paddington Mundagowa for helping to present our data about cervical cancer screening within the LGBTQ+ community at the American Public Health Association annual conference this past weekend. We also put together a research deep dive for those of you who want to learn more. ▶️ Around 13% of our clinical study participants identified as gay, lesbian, bisexual, pansexual, or queer, while 2% identified as trans, gender non-conforming, or genderqueer. ▶️ Research shows LGBTQ+ individuals are 50% less likely to engage in cervical cancer screening, often because of provider biases and feeling uncomfortable with the speculum exam. ▶️ In our study, we consistently see that LGBTQ+ individuals preferred screening with the Teal Wand, and felt empowered and in control when doing so. We hope that the Teal Wand can bring a crucial screening option to this community, and all those who are underscreened.* Check out our APHA poster at https://bit.ly/4hgZpGd. *The Teal Health Cervical Cancer Screening device is an Investigational Device and is under review by the US FDA. #tealhealth #womenshealth #lgbtqhealth #papsmear #femtech

It has been a full week! ▶️Our CEO, Kara Egan spoke at the HLTH USA conference to announce our FDA submission and share details of our patient preference data report, which demonstrated 94% of women prefer the Teal Wand to in-person collection - and so much more! You can see the details here: https://bit.ly/3NBuMxx ▶️We spent time within the IDEO booth, our extraordinary partners in the Teal Wand design ▶️Capped it off with Kara having the honor to attend a Women's Health gathering to discuss our work to eradicate cervical cancer in the U.S. with the one and only First Lady Jill Biden who is leading the efforts of the White House Women's Health Research Initiative. 👏👏 #tealhealth #womenshealth #femtech #HLTHUSA

Big News Day! From the stage at HLTH Inc. our CEO, Kara Egan, today announced we have submitted our Teal Wand at-home cervical cancer screening to the FDA and shared a report showing 94% of women prefer at-home cervical cancer screening. This submission, which received FDA Breakthrough Device Designation in May of this year, is the final step before making the Teal Wand commercially available. Screening with the Teal Wand will address barriers to cervical cancer screening and give millions of women and people with a cervix an alternative method for screening, one that is convenient, comfortable, and private. Teal Health’s SELF-CERV clinical trial, which completed enrollment earlier this year, has demonstrated strong clinical performance and an overwhelming preference for the Teal Wand. While pending approval, you can view Teal Health's report, which shares a glimpse into their study’s diverse demographic profile and the participants’ experiences with the Teal Wand. https://bit.ly/3UiuGhP

Teal Health is ready to head to Vegas for the Hlth Conference next week! Our CEO, Kara Egan, will be taking the stage to share exciting updates about Teal Health's mission to get every woman screened for cervical cancer. Following our recent $1.68 million SBIR grant from the National Cancer Institute (NCI), Kara will be talking about our continued momentum towards geting the Teal Wand™ into your hands and homes and what’s next for our revolutionary at-home cervical cancer screening technology. 🗓 When: Monday, October 21st 🕑 Time: 2:20 PM - 2:30 PM PT 📍 Where: Newsroom Stage at HLTH Can’t make it? Stay tuned for more updates to be shared on social and at getteal.com after Kara’s announcement! #HLTH2024 #WomensHealth #CervicalCancerPrevention #TealHealth #HealthcareInnovation #SBIRGrant

Big News from Teal Health: We’ve been awarded a $1.68 million SBIR Grant from the National Cancer Institute (NCI), part of The National Institutes of Health (NIH), to support the development and validation of our at-home cervical cancer screening technology, the Teal Wand™. The Teal Wand is a purpose-built device that allows a woman to collect her own vaginal sample for human papillomavirus (HPV) testing, a critical piece in cervical cancer prevention - all from the comfort, convenience, and privacy of her home. This grant is will help us bring this life-saving technology to more women, particularly those from underserved and underrepresented communities. Kara Egan, CEO of Teal Health, shares, "We're honored that the NIH recognizes the importance of our at-home screening technology in increasing access to preventive care and cancer screenings for women in the US. This funding brings us closer to our goal of providing women greater autonomy over their health while advancing the fight to eradicate cervical cancer." This award also recognizes the incredible work of our research partners and the diverse group of clinical trial participants who have been instrumental in this journey. We are excited about the impact this grant will have on our ability to expand access to critical preventive care and improve outcomes for women nationwide. Thank you to the National Cancer Institute for your support and belief in our mission to get all women screened for cervical cancer – working towards eradicating this preventable disease. Stay tuned for more updates as we continue to drive innovation in women’s healthcare! *The Teal Health Cervical Cancer Screening device is an Investigational Device and is not yet approved by the US FDA. #WomensHealth #CervicalCancerScreening #Innovation #SBIRGrant #HealthcareAccess #TealHealth #EquityInHealth Read Full Release Here: https://lnkd.in/gGmst3Um

We're thrilled to share that Teal Health has been selected as a spoke in the ARPA-H Investor Catalyst Hub network! We are excited to join this nationwide effort focused on driving innovative advancements in science and medicine, bringing us closer to equitable healthcare and better outcomes for all. #ARPAH #ARPANETH #MedTech #HealthTech #InvestorCatalystHub #HealthInnovation

We are excited to share that Teal Health won the pitch contest during the Culture Shifting Summit in Silicon Valley last week. The Culture Shifting Summit celebrates innovation and diversity, providing a platform for underrepresented voices to come together to make big changes in the venture and startup community. It was wonderful to be in a room of so many inspiring people and to have them recognize the importance of Teal Health's solution in transforming healthcare access for women. #CultureShiftingSummit #DiversityInTech #TealHealth #WomenInHealthcare #CervicalCancerAwareness #HealthEquity #InnovatingHealthcare

We’re excited to be highlighted in this article from The New York Times, outlining the evolution and new innovations in cervical cancer screenings. The future of at-home testing is within reach and we’re proud that Teal Health is leading the way, striving to bring the first FDA-approved at-home cervical cancer screening to all women across the United States. Check out the article by Danielle Friedman to learn more about this alternative to the in-office pap smear. #tealhealth #womenshealth #papsmear #cervicalcancerscreening #femtech https://lnkd.in/ebxUwsN7

Thank you Dezeen for showcasing the design of our Teal Wand at-home cervical cancer screening device. Changing an 80+ year Pap smear experience and replacing an 150+ year old speculum takes some creative thinking and thoughtful research. We have a great design partner in IDEO, who shares in our vision to ensure the design is intuitive and comfortable for all body types and health literacy levels. The Teal Wand has since been through multiple clinical trials, including a nationwide study across 17 leading medical organizations and has led to receiving Breakthrough Device Designation from the FDA. We believe in the power of design and can't wait to get the Teal Wand in the hands of people who need it. https://lnkd.in/gj3e6wvE

We are honored to be among the founding members of the Biospecimen Management Consortium (BMC), which will work to develop best practices and standards across the industry; streamline biospecimen lifecycle operations and data management; and shape regulatory policy. At Teal, we are passionate about innovating in the women's health space and advancing clinical research.